drugset / Trial / NCT01306513

Safety and Feasibility Study of Administration of Mesenchymal Stemcells for Treatment of Emphysema

NCT01306513

Phase 1 Completed 10 enrolled Leiden University Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to show safety and feasibility to administer patients own mesenchymal stem cells to show signs of repair of emphysematous lung tissue

Timeline

Start
2010-10
Primary completion
2012-06
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy Intravenous

Indications